Why Does Cirrhosis Cause Anemia: Key Mechanisms

Cirrhosis causes anemia through at least five distinct mechanisms, and most patients experience more than one at the same time. Roughly 70% of hospitalized cirrhosis patients are anemic, and the worse the liver disease, the lower hemoglobin levels tend to fall. Understanding why this happens starts with recognizing that the liver sits at the center of blood production, nutrient storage, and circulation, so when it fails, red blood cells take hits from multiple directions.

Blood Loss From the GI Tract

The most immediate cause of anemia in cirrhosis is bleeding. A scarred liver resists blood flow, which forces pressure back into the veins of the esophagus and stomach. These swollen veins, called varices, are fragile and can rupture. Bleeding from esophageal varices carries a 10% to 20% mortality rate over six weeks, and even when the bleeding isn’t dramatic, it can be chronic and slow enough to drain iron stores over time.

Beyond varices, the high pressure in the portal vein system also damages the stomach lining itself, a condition called portal hypertensive gastropathy. This affects anywhere from 20% to 80% of cirrhosis patients and can cause a slow, steady ooze of blood that shows up as iron deficiency anemia. Because the bleeding is often invisible to the patient, the resulting anemia can worsen for months before anyone identifies the source.

The Spleen Destroys Red Blood Cells Faster

When blood can’t flow easily through a scarred liver, it backs up into the spleen, causing it to enlarge. A bigger spleen traps and holds more blood cells than normal, and the immune cells inside it become more aggressive at breaking down red blood cells. This combination of pooling and destruction is called hypersplenism. The larger the spleen grows, the more red blood cells it removes from circulation, and the lower the blood count drops. This is one reason cirrhosis patients can remain anemic even when they aren’t actively bleeding.

Inflammation Locks Away Iron

Cirrhosis keeps the body in a state of chronic low-grade inflammation. Inflammatory signals, particularly a molecule called IL-6, trigger the liver to produce a hormone called hepcidin. Hepcidin acts like a gatekeeper: it blocks iron absorption in the gut and prevents immune cells from releasing the iron they’ve recycled from old red blood cells. The result is that iron gets trapped in storage, unavailable for making new red blood cells, even though total iron in the body may be normal or even elevated. This pattern, sometimes called anemia of chronic disease, means the bone marrow is essentially starved of a key ingredient despite adequate reserves elsewhere.

Nutritional Deficiencies, Especially Folate

The liver is the primary organ for storing and processing folate, one of the B vitamins essential for building new red blood cells. When the liver is damaged, its ability to maintain folate stores drops. For people whose cirrhosis is alcohol-related, the problem compounds: alcohol directly disrupts folate metabolism, impairing DNA synthesis and reducing the production of important antioxidants that protect liver cells. Without enough folate, the bone marrow produces fewer red blood cells, and the ones it does produce are often abnormally large, a pattern called macrocytic anemia.

Vitamin B12 deficiency can contribute in a similar way, though it’s less common than folate deficiency in cirrhosis. Alcohol also interferes with the absorption of other nutrients that support red blood cell production, creating a cascade of deficiencies that stack on top of each other.

Spur Cell Anemia: Membrane Damage

In advanced cirrhosis, the liver loses its ability to properly process cholesterol and other fats. This leads to an abnormal ratio of cholesterol to other lipids in red blood cell membranes. The excess cholesterol makes the cells stiff and misshapen, sprouting thorn-like projections that give them a spiky appearance under a microscope. These deformed cells, called spur cells or acanthocytes, are fragile and break apart much faster than healthy red blood cells. Combined with hypersplenism, which accelerates their destruction even further, spur cell anemia can cause a rapid, severe drop in hemoglobin. It typically appears in the most advanced stages of liver disease.

Direct Bone Marrow Suppression

In alcohol-related cirrhosis, the bone marrow itself takes damage. Alcohol is directly toxic to the cells that produce red blood cells, slowing their growth and maturation. This means the factory responsible for replacing lost red blood cells is running at reduced capacity at the same time that destruction and blood loss are increasing demand. Viral hepatitis can also impair marrow function, though through different mechanisms. The net effect is the same: the body can’t produce red blood cells fast enough to keep up with losses.

How Red Blood Cell Size Helps Identify the Cause

One of the most useful clues for figuring out which type of anemia a cirrhosis patient has is the average size of their red blood cells, measured as mean corpuscular volume (MCV). Cells smaller than 80 femtoliters point toward iron deficiency from chronic blood loss. Cells in the normal range (80 to 100 femtoliters) suggest anemia of chronic disease or hypersplenism. Cells larger than 100 femtoliters indicate folate or B12 deficiency, or direct alcohol toxicity to the bone marrow. In practice, many cirrhosis patients have overlapping causes, so the MCV may reflect whichever mechanism is dominant at that moment.

Anemia Severity Tracks With Liver Disease

Anemia in cirrhosis isn’t just a side effect; it’s a marker of how far the disease has progressed. Studies show a strong inverse correlation between hemoglobin levels and standard measures of liver disease severity. Patients with the most advanced cirrhosis consistently have the lowest hemoglobin. Every 10 g/L drop in hemoglobin is associated with roughly a 7% increase in the risk of death within 90 days and a 6% increase in one-year mortality. Severe anemia is an independent risk factor for death, meaning it worsens outcomes beyond what liver disease alone would predict.

This relationship runs in both directions. Worsening liver function drives anemia through all the mechanisms described above, and the resulting anemia places additional stress on the heart and other organs, accelerating decline. Correcting anemia when possible, whether through addressing bleeding, replacing nutrients, or managing the underlying liver disease, can meaningfully improve quality of life and outcomes.